Correlation Between Tarsus Pharmaceuticals and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and X4 Pharmaceuticals, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and X4 Pharmaceuticals.
Diversification Opportunities for Tarsus Pharmaceuticals and X4 Pharmaceuticals
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tarsus and XFOR is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and X4 Pharmaceuticals
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.22 times more return on investment than X4 Pharmaceuticals. However, Tarsus Pharmaceuticals is 4.63 times less risky than X4 Pharmaceuticals. It trades about 0.3 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 3,967 in Tarsus Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 999.00 from holding Tarsus Pharmaceuticals or generate 25.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| X4 Pharmaceuticals |
Tarsus Pharmaceuticals and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and X4 Pharmaceuticals
The main advantage of trading using opposite Tarsus Pharmaceuticals and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Tarsus Pharmaceuticals vs. Bright Minds Biosciences | Tarsus Pharmaceuticals vs. HP Inc | Tarsus Pharmaceuticals vs. Intel | Tarsus Pharmaceuticals vs. Chevron Corp |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |